Evolution of immunobiological changes and their significance for the treatment of patients with Non-Hodgkin’s lymphoma
Introduction. Non-Hodgkin’s lymphoma (NHL) shows clonal and uncontrolled proliferation of immature lymphoid precursors. The aim of the study. Dynamic analysis of immunobiological and immunophenotypic parameters in the treatment of patients with NHL, and recognition of immunological remissions....
Main Author: | Aliona NICORICI |
---|---|
Format: | Article |
Language: | English |
Published: |
Balkan Medical Union
2019-06-01
|
Series: | Archives of the Balkan Medical Union |
Subjects: | |
Online Access: | https://umbalk.org/wp-content/uploads/2019/06/01.EVOLUTION-OF-IMMUNOBIOLOGICAL-CHANGES.pdf |
Similar Items
-
Abdominal Lymphocyte-Depleted Hodgkin Lymphoma: A Rare Presentation
by: Kasinathan G, et al.
Published: (2019-11-01) -
Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience
by: Natalia S. Tsaplina, et al.
Published: (2022-11-01) -
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
by: Natalie S. Grover, et al.
Published: (2015-09-01) -
Immunotherapy in indolent Non-Hodgkin's Lymphoma
by: Ghid Amhaz, et al.
Published: (2022-01-01) -
Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment
by: Letizia Polito, et al.
Published: (2013-10-01)